Clinicians should pay more attention to the debilitating symptoms of adolescent fatigue, say commentators responding to a survey that shows prolonged fatigue may indicate severe depression or anxiety.
Do patients with a left ventricular assist device (LVAD) have a worse sex life, afraid to damage it, or a better one, because they feel better? Either way, studies say, they should be encouraged to discuss the question.
A population-based case control study leads to reason to believe that taking either a selective-serotonin reductase inhibitor (SSRI) or a non-selective monoamine reuptake inhibitor slightly increases the risks for autism among the offspring of pregnant women with a history of depression.
Experts offer an update on current research in hedgehog signaling pathway inhibition in basal cell carcinoma, including efficacy and toxicity results for vismodegib (Erivedge), the first oral medication to win FDA approval for metastatic BCC treatment.
Small, twice-daily doses of rivaroxaban may offer an effective strategy to reduce thrombotic events in patients following ST-elevation myocardial infarction (STEMI).
New guidelines from the American College of Gastroenterology point out the increasing prevalence of celiac disease, and the challenges in diagnosis and treatment.
Not only are mobile apps good at assessing schizophrenia, they may be more acceptable to patients. Future apps may broaden the use of mobile technology to sense mental status.
Co-infection with a respiratory virus was not associated with worse outcomes among patients infected during the H1N1 influenza A virus pandemic of 2009. Still, a population-based prospective study shows that non-influenza viruses can help to shape a flu outbreak.
Nonsmall-cell lung cancer (NSCLC) patients lived significantly longer after definitive radiation therapy if they continued to take beta-blockers during treatment, according to clinicians from M.D. Anderson Cancer Center in Houston.
More evidence that brain stimulation eases depression. Add it to sertraline, and both treatments are more effective. Studying brain responses to this kind of stimulation should also increase our knowledge and allow tailored treatment.
Genetic subtypes of disease don't explain why breast cancer is more aggressive among African-American than Caucasian women. But genotypes may explain differences in immunity to HER2.
